Currently approved antiviral therapy for HCV is PEG-IFN plus RBV for 48 weeks in genotypes 1 and 4, and for 24 weeks for genotypes 2 and 3. Acute HCV infection is usually asymptomatic and difficult in... This description may be from another edition of this product.